EP1001777A4 - Fibrinogen receptor antagonists - Google Patents

Fibrinogen receptor antagonists

Info

Publication number: EP1001777A4
Authority: EP; European Patent Office
Prior art keywords: receptor antagonists; fibrinogen receptor; fibrinogen; antagonists; receptor
Prior art date: 1997-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98935967A

Other languages

German (de)

French (fr)

Other versions

EP1001777A1 (en

Inventor

Dirk Heerding

James M Samanen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-25

Filing date

1998-07-23

Publication date

2002-10-09

1998-07-23 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2000-05-24 Publication of EP1001777A1 publication Critical patent/EP1001777A1/en

2002-10-09 Publication of EP1001777A4 publication Critical patent/EP1001777A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP98935967A 1997-07-25 1998-07-23 Fibrinogen receptor antagonists Withdrawn EP1001777A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US5378897P	1997-07-25	1997-07-25
US6354597P	1997-10-28	1997-10-28
US63545P		1997-10-28
PCT/US1998/015288 WO1999004796A1 (en)	1997-07-25	1998-07-23	Fibrinogen receptor antagonists
US53788P		2008-05-16

Publications (2)

Publication Number	Publication Date
EP1001777A1 EP1001777A1 (en)	2000-05-24
EP1001777A4 true EP1001777A4 (en)	2002-10-09

Family

ID=26732245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98935967A Withdrawn EP1001777A4 (en)	1997-07-25	1998-07-23	Fibrinogen receptor antagonists

Country Status (6)

Country	Link
EP (1)	EP1001777A4 (en)
JP (1)	JP2002509547A (en)
AU (1)	AU8510398A (en)
CA (1)	CA2297909A1 (en)
CO (1)	CO4970784A1 (en)
WO (1)	WO1999004796A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997025323A1 (en) *	1996-01-11	1997-07-17	Smithkline Beecham Corporation	Fibrinogen receptor antagonists

1998
- 1998-07-23 JP JP51008299A patent/JP2002509547A/en active Pending
- 1998-07-23 WO PCT/US1998/015288 patent/WO1999004796A1/en not_active Application Discontinuation
- 1998-07-23 CA CA002297909A patent/CA2297909A1/en not_active Abandoned
- 1998-07-23 AU AU85103/98A patent/AU8510398A/en not_active Abandoned
- 1998-07-23 EP EP98935967A patent/EP1001777A4/en not_active Withdrawn
- 1998-07-24 CO CO98042201A patent/CO4970784A1/en unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997025323A1 (en) *	1996-01-11	1997-07-17	Smithkline Beecham Corporation	Fibrinogen receptor antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9904796A1 *

Also Published As

Publication number	Publication date
EP1001777A1 (en)	2000-05-24
CA2297909A1 (en)	1999-02-04
CO4970784A1 (en)	2000-11-07
AU8510398A (en)	1999-02-16
JP2002509547A (en)	2002-03-26
WO1999004796A1 (en)	1999-02-04

Legal Events

Date	Code	Title	Description
2000-04-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-05-24	17P	Request for examination filed	Effective date: 20000117
2000-05-24	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): BE CH DE ES FR GB IT LI NL
2002-10-09	A4	Supplementary search report drawn up and despatched	Effective date: 20020826
2002-10-09	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): BE CH DE ES FR GB IT LI NL
2002-10-09	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 31/495 A, 7C 07D 237/00 B, 7C 07D 211/62 B
2004-03-17	17Q	First examination report despatched	Effective date: 20040128
2004-10-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-12-08	18D	Application deemed to be withdrawn	Effective date: 20040508
2007-03-02	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1028552 Country of ref document: HK

Publication	Publication Date	Title
EP0912175A4 (en)	1999-09-08	Fibrinogen receptor antagonists
EP0810994A4 (en)	1998-05-06	Fibrinogen receptor antagonists
HU9603525D0 (en)	1997-02-28	Vironectin receptor antagonists
EP1047425A4 (en)	2009-04-22	Integrin receptor antagonists
EP0885205A4 (en)	2002-11-27	Fibrinogen receptor antagonists
EP0866705A4 (en)	1999-03-03	Fibrinogen receptor antagonists
GB9817910D0 (en)	1998-10-14	CCR-3 receptor antagonists
GB9405317D0 (en)	1994-04-27	Fibrinogen receptor antagonists
EP1007051A4 (en)	2001-08-29	Integrin receptor antagonists
EP0885213A4 (en)	1999-04-28	Fibrinogen receptor antagonists
EP0796098A4 (en)	1998-04-29	Fibrinogen receptor antagonists
EP0880511A4 (en)	1999-06-16	Integrin receptor antagonists
HK1031726A1 (en)	2001-06-22	Thrombin receptor antagonists
EP0801650A4 (en)	1998-05-06	Fibrinogen receptor antagonists
HU9502028D0 (en)	1995-09-28	Fibrinogen receptor antagonists
EP1027337A4 (en)	2002-04-03	Integrin receptor antagonists
IL134301A0 (en)	2001-04-30	2-acylaminopropanamines as tachykinin receptor antagonists
EP0794779A4 (en)	1998-04-29	Fibrinogen receptor antagonists
GB9515852D0 (en)	1995-10-04	Fibrinogen receptor antagonists
EP1023295A4 (en)	2001-01-24	Fibrinogen receptor antagonist prodrugs
IL134155A0 (en)	2001-04-30	2-acylaminopropanamines as tachykinin receptor antagonists
EP0800395A4 (en)	1998-04-29	Fibrinogen receptor antagonists
EP0781133A4 (en)	1997-12-10	Fibrinogen receptor antagonists
AU6826498A (en)	1998-10-12	Endotholin receptor antagonists
GB9516643D0 (en)	1995-10-18	Fibrinogen receptor antagonists